Diseases & Disorders
(G30)
IRS Verified
DX Registered
990 on File
CANCER 101 INC
Financial strength (30%)
87/100
Reliability (20%)
45/100
Effectiveness (25%)
66/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
To empower cancer patients and their caregivers to take control over their diagnoses from the moment they learn they have cancer, a recurrence or metastasis through ten years of follow-up care. Having a plan of attack, the means to stay organized, and access to appropriate resources and information is half the battle to getting through a cancer diagnosis. CANCER101 (C101) meets the patient and caregiver on the front line and turns what is often a chaotic experience into a calm and organized plan of attack. And just as important, C101 is there after the treatments are over to help survivors manage important post-treatment appointments, medications and survivorship issues.
Financial Overview — FY 2024
$1.6M
Total Revenue
$805K
Total Expenses
$4.0M
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
89.9%
Fundraising Efficiency
N/A
Operating Reserve
59.33x
Liability-to-Asset
0.1%
Revenue Diversification
85.7%
Executive Compensation
$264K
Compared with Peers
FY 2024
Compared with 1,541 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
89.9% | 83.1% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
7.8% | 10.9% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
2.3% | 0.3% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
59.3 mo | 12.0 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.1% | 0.7% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
85.7% | 93.9% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
26.1% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
21.5% | 9.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
49.0% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $1.6M | $805K | $4.0M | 89.9% | 2 |
| 2023 | $1.3M | $663K | $3.2M | 92.9% | 1 |
| 2022 | $2.2M | $616K | $2.6M | 95.0% | 2 |
| 2021 | $643K | $379K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.